Business · India Bureau
Maharashtra Commission Finds Doctor Liable for Crossing Professional Boundaries
A Maharashtra State Commission has held a medical practitioner accountable for stepping beyond his professional remit by functioning as a commercial intermediary in surrogacy arrangements. The ruling underscores consumer protection standards in assisted reproductive services across India.
LSN India ·

The Maharashtra State Consumer Protection Commission has concluded that a doctor breached professional boundaries by engaging in commercial activities beyond the scope of medical practice. The commission determined that the practitioner had functioned not merely as a healthcare provider but as a trader and intermediary facilitating surrogacy arrangements, thereby violating established norms governing medical professionals.
The case highlights growing concerns about the commercialization of assisted reproductive technologies in India, where surrogacy services operate in a complex regulatory environment. Medical professionals offering fertility and surrogacy services are expected to maintain clear demarcation between legitimate medical practice and commercial intermediation, which can expose consumers to exploitation and inadequate legal protections.
This ruling reinforces the principle that doctors must confine their activities to medical service delivery and cannot simultaneously operate as agents or facilitators in commercial transactions involving reproductive services. The commission's decision establishes precedent for consumer protection standards in the assisted reproduction sector, signaling increased scrutiny of practitioners who blur the lines between healthcare provision and commercial brokerage.
The judgment carries implications for medical practitioners across India offering surrogacy-related services, emphasizing that consumer protection laws apply to fertility treatments and that professional accountability extends to preventing practitioners from exploiting patients through dual commercial roles. Regulators and professional bodies are expected to strengthen guidelines ensuring that assisted reproductive services prioritize patient welfare over profit-driven intermediation.